Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127666901 | 12766690 | 1 | I | 20160701 | 20160913 | 20160921 | 20160921 | EXP | JP-PFIZER INC-2016437926 | PFIZER | 72.00 | YR | F | Y | 29.00000 | KG | 20160921 | PH | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127666901 | 12766690 | 1 | PS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 4.5 G, 3X/DAY | 148 | G | Y | 50684 | 4.5 | G | TID | ||||
127666901 | 12766690 | 2 | SS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 13.5 G, DAILY | 148 | G | Y | 50684 | 13.5 | G | |||||
127666901 | 12766690 | 3 | C | MIYA-BM | CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 | 1 | Oral | UNK | 0 | ||||||||||
127666901 | 12766690 | 4 | C | HOKUNALIN /00654901/ | TULOBUTEROL | 1 | UNK | 0 | |||||||||||
127666901 | 12766690 | 5 | C | KCL | POTASSIUM CHLORIDE | 1 | Intravenous drip | UNK | 0 | ||||||||||
127666901 | 12766690 | 6 | C | SOLDEM 3A | CARBOHYDRATESPOTASSIUM CHLORIDESODIUM CHLORIDESODIUM LACTATE | 1 | Intravenous drip | UNK | 0 | ||||||||||
127666901 | 12766690 | 7 | C | VITAMEDIN /00176001/ | 2 | Intravenous (not otherwise specified) | UNK | 0 | |||||||||||
127666901 | 12766690 | 8 | C | ALDACTONE A | SPIRONOLACTONE | 1 | Oral | UNK | 0 | ||||||||||
127666901 | 12766690 | 9 | C | ATELEC | CILNIDIPINE | 1 | Oral | UNK | 0 | ||||||||||
127666901 | 12766690 | 10 | C | CARBOCISTEINE | CARBOCYSTEINE | 1 | Oral | UNK | 0 | ||||||||||
127666901 | 12766690 | 11 | C | SLOW-K | POTASSIUM CHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
127666901 | 12766690 | 12 | C | YOKUKANSAN | HERBALS | 1 | Oral | UNK | 0 | ||||||||||
127666901 | 12766690 | 13 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | UNK | 0 | ||||||||||
127666901 | 12766690 | 14 | C | SOLYUGEN F | 2 | Intravenous drip | UNK | 0 | |||||||||||
127666901 | 12766690 | 15 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127666901 | 12766690 | 1 | Pneumonia |
127666901 | 12766690 | 2 | Diffuse panbronchiolitis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127666901 | 12766690 | LT |
127666901 | 12766690 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127666901 | 12766690 | Acute kidney injury | |
127666901 | 12766690 | Renal tubular necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127666901 | 12766690 | 1 | 20160610 | 20160620 | 0 | |
127666901 | 12766690 | 2 | 20160624 | 20160701 | 0 | |
127666901 | 12766690 | 4 | 20160616 | 0 | ||
127666901 | 12766690 | 5 | 20160612 | 20160623 | 0 | |
127666901 | 12766690 | 6 | 20160610 | 20160630 | 0 | |
127666901 | 12766690 | 7 | 20160611 | 20160623 | 0 | |
127666901 | 12766690 | 8 | 20160629 | 20160707 | 0 | |
127666901 | 12766690 | 9 | 20160624 | 20160707 | 0 | |
127666901 | 12766690 | 10 | 20160624 | 20160712 | 0 | |
127666901 | 12766690 | 11 | 20160623 | 20160707 | 0 | |
127666901 | 12766690 | 12 | 20160620 | 20160707 | 0 | |
127666901 | 12766690 | 13 | 20160624 | 20160712 | 0 | |
127666901 | 12766690 | 14 | 20160624 | 20160628 | 0 | |
127666901 | 12766690 | 15 | 20160610 | 20160628 | 0 |